The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, P.
Right arrow Articles by Plevin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, P.
Right arrow Articles by Plevin, R.
The Journal of Immunology, 2004, 173: 3297-3304.
Copyright © 2004 by The American Association of Immunologists

Inhibition of Lipopolysaccharide-Induced Macrophage IL-12 Production by Leishmania mexicana Amastigotes: The Role of Cysteine Peptidases and the NF-{kappa}B Signaling Pathway1

Pamela Cameron3,2,{dagger}, Adrienne McGachy2,*, Mary Anderson{dagger}, Andrew Paul{dagger}, Graham H. Coombs{ddagger}, Jeremy C. Mottram§, James Alexander4,* and Robin Plevin{dagger}

Departments of * Immunology and {dagger} Physiology and Pharmacology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom; {ddagger} Department of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom; and § Wellcome Center for Molecular Parasitology, Anderson College, University of Glasgow, Glasgow, United Kingdom

Infection with lesion-derived Leishmania mexicana amastigotes inhibited LPS-induced IL-12 production by mouse bone marrow-derived macrophages. This effect was associated with expression of cysteine peptidase B (CPB) because amastigotes of CPB deletion mutants had limited ability to inhibit IL-12 production, whereas preincubation of cells with a CPB inhibitor, cathepsin inhibitor IV, was able to suppress the effect of wild-type amastigotes. Infection with wild-type amastigotes resulted in a time-dependent proteolytic degradation of I{kappa}B{alpha} and I{kappa}B{beta} and the related protein NF-{kappa}B. This effect did not occur with amastigotes of CPB deletion mutants or wild-type promastigotes, which do not express detectable CPB. NF-{kappa}B DNA binding was also inhibited by amastigote infection, although nuclear translocation of cleaved fragments of p65 NF-{kappa}B was still observed. Cysteine peptidase inhibitors prevented I{kappa}B{alpha}, I{kappa}B{beta}, and NF-{kappa}B degradation induced by amastigotes, and recombinant CPB2.8, an amastigote-specific isoenzyme of CPB, was shown to degrade GST-I{kappa}B{alpha} in vitro. LPS-mediated I{kappa}B{alpha} and I{kappa}B{beta} degradation was not affected by these inhibitors, confirming that the site of degradation of I{kappa}B{alpha}, I{kappa}B{beta}, and NF-{kappa}B by the amastigotes was not receptor-driven, proteosomal-mediated cleavage. Infection of bone marrow macrophages with amastigotes resulted in cleavage of JNK and ERK, but not p38 MAPK, whereas preincubation with a cysteine peptidase inhibitor prevented degradation of these proteins, but did not result in enhanced protein kinase activation. Collectively, our results suggest that the amastigote-specific cysteine peptidases of L. mexicana are central to the ability of the parasite to modulate signaling via NF-{kappa}B and consequently inhibit IL-12 production.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. Liu, L. P. Carvalho, S. Bhattacharya, C. J. Carbone, K. G. S. Kumar, N. A. Leu, P. M. Yau, R. G. K. Donald, M. J. Weiss, D. P. Baker, et al.
Mammalian Casein Kinase 1{alpha} and Its Leishmanial Ortholog Regulate Stability of IFNAR1 and Type I Interferon Signaling
Mol. Cell. Biol., December 15, 2009; 29(24): 6401 - 6412.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Bryson, S. Besteiro, H. A. McGachy, G. H. Coombs, J. C. Mottram, and J. Alexander
Overexpression of the Natural Inhibitor of Cysteine Peptidases in Leishmania mexicana Leads to Reduced Virulence and a Th1 Response
Infect. Immun., July 1, 2009; 77(7): 2971 - 2978.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
T. H. Mogensen
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. P. Carvalho, E. J. Pearce, and P. Scott
Functional Dichotomy of Dendritic Cells following Interaction with Leishmania braziliensis: Infected Cells Produce High Levels of TNF-{alpha}, whereas Bystander Dendritic Cells Are Activated to Promote T Cell Responses
J. Immunol., November 1, 2008; 181(9): 6473 - 6480.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Soong
Modulation of Dendritic Cell Function by Leishmania Parasites
J. Immunol., April 1, 2008; 180(7): 4355 - 4360.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
R. M. MUKBEL, C. PATTEN JR., K. GIBSON, M. GHOSH, C. PETERSEN, and D. E. JONES
MACROPHAGE KILLING OF LEISHMANIA AMAZONENSIS AMASTIGOTES REQUIRES BOTH NITRIC OXIDE AND SUPEROXIDE
Am J Trop Med Hyg, April 1, 2007; 76(4): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Saito, M. Matsuura, and Y. Hirai
Regulation of Lipopolysaccharide-Induced Interleukin-12 Production by Activation of Repressor Element GA-12 through Hyperactivation of the ERK Pathway.
Clin. Vaccine Immunol., August 1, 2006; 13(8): 876 - 883.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pelletier and D. Girard
Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells
J. Immunol., July 1, 2006; 177(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Olivier, D. J. Gregory, and G. Forget
Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View
Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.